Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cathine is a psychoactive drug with stimulant properties belonging to the phenethylamine and amphetamine chemical classes. It is found naturally in the khat plant (Catha edulis) and acts as a central nervous system stimulant. Cathine has been used for its euphoric and appetite-suppressing effects but is not approved for medical use in most countries. In the United States it is classified as a Schedule IV controlled substance[1][2][3]. Its mechanism of action involves promoting norepinephrine release from nerve terminals[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cathine.